DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+15.82%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$214M
AUM Growth
+$214M
(+3.9%)
Cap. Flow
-$17.1M
Cap. Flow
% of AUM
-8%
Top 10 Holdings %
Top 10 Hldgs %
48%
Holding
93
New
17
Increased
13
Reduced
25
Closed
14
Top Buys
| 1 |
VYNE Therapeutics
VYNE
|
$2.53M |
| 2 |
Indaptus Therapeutics
INDP
|
$2.5M |
| 3 |
Kura Oncology
KURA
|
$2.05M |
| 4 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$1.92M |
| 5 |
Larimar Therapeutics
LRMR
|
$1.67M |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$3.97M |
| 2 |
Insulet
PODD
|
$2.82M |
| 3 |
argenx
ARGX
|
$2.67M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$2.32M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
$2.16M |
Sector Composition
| 1 | Healthcare | 86.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CGNT
76
DELISTED
Cogentix Medical, Inc.
CGNT
| – | – |
-310,382
| Closed | -$1.2M |
|
|
CMTA
77
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| – | – |
-105,000
| Closed | -$1.59M |
|
|
SRRA
78
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| – | – |
-79,969
| Closed | -$166K |
|
|
KA
79
DELISTED
Kineta, Inc. Common Stock
KA
| – | – |
-267,100
| Closed | -$1.27M |
|
|
MTVA
80
MetaVia Inc. Common Stock
MTVA
$16.2M
| – | – |
-100,000
| Closed | -$651K |
|
81
Tandem Diabetes Care
TNDM
$834M
| – | – |
-60,000
| Closed | -$298K |
|
|
SCNI
82
Scinai Immunotherapeutics
SCNI
$1.61M
| – | – |
-3,399
| Closed | -$18K |
|
83
scPharmaceuticals
SCPH
$296M
| – | – |
-55,844
| Closed | -$692K |
|
84
Spero Therapeutics
SPRO
$117M
| – | – |
-29,544
| Closed | -$421K |
|